CVS Health (NYSE: CVS) saw its net income expand by $4.2 billion or 101% y-o-y to $8.3 billion in 2023. This can primarily be attributed to the opioid litigation charges included in the 2022 results.

CVS Health is a company that has transformed itself into a health powerhouse that earns roughly $355 billion in annual revenue. CVS Health serves over 100 million consumers, including 55 million ...

Shares of CVS Health have been under pressure amid weaker-than-expected earnings. A new management team will attempt to improve the company's profitability. CVS Health stock offers investors good ...

CVS Health experienced a significant turnaround in 2025, with shares up nearly 50% after a 44% decline in 2024. The recent rally is not driven by great results or strong guidance under new CEO ...